Published in Pediatr Nephrol on August 20, 2005
Dialysate CA125 levels after 5 years on continuous peritoneal dialysis. Pediatr Nephrol (2011) 0.75
Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol (2002) 3.33
Clinical value of standardized equilibration tests in CAPD patients. Blood Purif (1989) 1.41
Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant (1995) 1.32
CA 125 secretion by peritoneal mesothelial cells. J Clin Pathol (1994) 1.21
Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis. J Am Soc Nephrol (2003) 1.02
Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Perit Dial Int (2002) 1.01
Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int (1997) 1.00
Peritoneal membrane transport function in children receiving long-term dialysis. J Am Soc Nephrol (1996) 0.97
Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD. Perit Dial Int (1995) 0.97
Cancer antigen 125 is locally produced in the peritoneal cavity during continuous ambulatory peritoneal dialysis. Perit Dial Int (1994) 0.96
Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters. Am J Kidney Dis (1997) 0.94
Dialysate CA125 in stable CAPD patients: no relation with transport parameters. Clin Nephrol (1995) 0.91
Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis. Perit Dial Int (2001) 0.90
Markers of peritoneal mesothelial cells during treatment with peritoneal dialysis. Adv Perit Dial (1997) 0.86
The longitudinal effect of a single peritonitis episode on peritoneal membrane transport in CAPD patients. Perit Dial Int (2000) 0.83
Peritoneal kinetics of cancer antigen 125 in peritoneal dialysis patients: the relationship with peritoneal outcome. Adv Perit Dial (1999) 0.82
Dialysate cancer antigen 125 levels in children treated with peritoneal dialysis. Adv Perit Dial (2000) 0.81
Necessity of correcting cancer antigen 125 appearance rates by body surface area. Adv Perit Dial (2000) 0.80
Peritoneal fluid markers of mesothelial cells and function. Adv Ren Replace Ther (1998) 0.79
Changes in peritoneal equilibration test values during long-term peritoneal dialysis in peritonitis-free children. Perit Dial Int (2001) 0.79
Influence of age, time, and peritonitis on peritoneal transport kinetics in children. Perit Dial Int (1999) 0.78
Effluent CA 125 concentration in chronic peritoneal dialysis patients: influence of PD duration, peritoneal transport and PD regimen. Kidney Blood Press Res (2003) 0.78
Evaluation of changes in serum and dialysate levels of cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients. Adv Perit Dial (1999) 0.77
Dialysate CA125 levels in stable peritoneal dialysis patients. Clin Nephrol (1999) 0.77
Strict blood-pressure control and progression of renal failure in children. N Engl J Med (2009) 5.71
Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med (2014) 4.70
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med (2012) 3.14
Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) (2005) 3.01
The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set. Arthritis Rheum (2005) 2.55
Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr (2004) 1.57
Percutaneous nephrolithotomy in children with cystine stone: long-term outcomes from a single institution. J Urol (2013) 1.48
Increased frequency of extremely skewed X chromosome inactivation in juvenile idiopathic arthritis. Arthritis Rheum (2009) 1.45
Takayasu arteritis in children. J Rheumatol (2008) 1.30
Peritonitis in children who receive long-term peritoneal dialysis: a prospective evaluation of therapeutic guidelines. J Am Soc Nephrol (2007) 1.23
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol (2014) 1.22
Genetic screening in adolescents with steroid-resistant nephrotic syndrome. Kidney Int (2013) 1.21
Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol (2006) 1.21
The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology. Clin J Am Soc Nephrol (2010) 1.21
Quality of life in children with chronic kidney disease (with child and parent assessments). Pediatr Nephrol (2010) 1.20
Enuresis: prevalence, risk factors and urinary pathology among school children in Istanbul, Turkey. Pediatr Int (2004) 1.17
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis (2012) 1.15
DNASE1L3 mutations in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum (2013) 1.13
Impact of global economic disparities on practices and outcomes of chronic peritoneal dialysis in children: insights from the International Pediatric Peritoneal Dialysis Network Registry. Perit Dial Int (2012) 1.10
Clinical variability of asphyxiating thoracic dystrophy (Jeune) syndrome: Evaluation and classification of 13 patients. Am J Med Genet A (2009) 1.06
Reduced systolic myocardial function in children with chronic renal insufficiency. J Am Soc Nephrol (2007) 1.06
Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol (2006) 1.01
MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura. J Rheumatol (2008) 0.99
NPHS2 (podicin) mutations in Turkish children with idiopathic nephrotic syndrome. Pediatr Nephrol (2007) 0.99
Blood volume monitoring to adjust dry weight in hypertensive pediatric hemodialysis patients. Pediatr Nephrol (2008) 0.96
Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy. Eur J Pediatr (2014) 0.93
Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia. Urol Oncol (2008) 0.93
The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association. Clin Exp Rheumatol (2011) 0.92
A child with primary Sjögren syndrome and a review of the literature. Clin Pediatr (Phila) (2007) 0.91
Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report. Nephrol Dial Transplant (2009) 0.91
Traditional and "new" cardiovascular risk markers and factors in pediatric dialysis patients. Pediatr Nephrol (2007) 0.90
Progression of coronary calcification in pediatric chronic kidney disease stage 5. Pediatr Nephrol (2008) 0.89
Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr (2007) 0.89
Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine. Life Sci (2007) 0.88
Chronic peritoneal dialysis in Turkish children: a multicenter study. Pediatr Nephrol (2005) 0.88
Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever. Rheumatol Int (2011) 0.88
Systemic lupus erythematosus due to Epstein-Barr virus or Epstein-Barr virus infection provocating acute exacerbation of systemic lupus erythematosus? Rheumatol Int (2005) 0.87
Serum chitotriosidase activity in patients with coronary artery disease. Circ J (2008) 0.87
Do infections trigger juvenile idiopathic arthritis? Rheumatol Int (2009) 0.86
The relationship between physical activity level, anxiety, depression, and functional ability in children and adolescents with juvenile idiopathic arthritis. Clin Rheumatol (2011) 0.85
Peritonitis rates and common microorganisms in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis. Pediatr Int (2009) 0.84
Leptin in nonalcoholic fatty liver disease. Ann Hepatol (2008) 0.84
Is it safe to use anti-TNF-α agents for tuberculosis in children suffering with chronic rheumatic disease? Rheumatol Int (2011) 0.84
Nephrocalcinosis as a complication of subcutaneous fat necrosis of the newborn. Turk J Pediatr (2013) 0.83
Impact of peritoneal transport characteristics on cardiac function in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report. Nephrol Dial Transplant (2010) 0.82
A case of catastrophic antiphospholipid syndrome in an adolescent girl with parvovirus B19 infection. Clin Pediatr (Phila) (2008) 0.82
Cardiopulmonary exercise testing in juvenile idiopathic arthritis. J Rheumatol (2004) 0.82
Pelvic MRI findings of juvenile-onset ankylosing spondylitis. Clin Rheumatol (2010) 0.81
FMF50: a score for assessing outcome in familial Mediterranean fever. Ann Rheum Dis (2014) 0.81
Analysis of MEFV exon methylation and expression patterns in familial Mediterranean fever. BMC Med Genet (2011) 0.81
Uveitis and anti nuclear antibody positivity in children with juvenile idiopathic arthritis. Indian Pediatr (2004) 0.81
Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus. Pediatr Nephrol (2012) 0.81
L-Dopa synthesis catalyzed by tyrosinase immobilized in poly(ethyleneoxide) conducting polymers. Int J Biol Macromol (2013) 0.80
Purified protein derivative response in juvenile idiopathic arthritis. J Rheumatol (2009) 0.80
Is Familial Mediterranean Fever a thrombotic disease or not? Eur J Pediatr (2007) 0.80
Efficacy of a land-based home exercise programme for patients with juvenile idiopathic arthritis: a randomized, controlled, single-blind study. J Rehabil Med (2012) 0.80
Abdominal manifestations of polyarteritis nodosa demonstrated with CT. Pediatr Radiol (2010) 0.80
The anemia of familial Mediterranean fever disease. Pediatr Hematol Oncol (2005) 0.79
Hepatitis B vaccination in juvenile systemic lupus erythematosus. Clin Exp Rheumatol (2011) 0.79
Malnutrition and its association with inflammation and vascular disease in children on maintenance dialysis. Pediatr Nephrol (2013) 0.79
Acute promyelocytic leukemia treated with idarubicin complicated by focal segmental glomerulosclerosis. J Pediatr Hematol Oncol (2010) 0.79
Left ventricular function by 'conventional' and 'tissue Doppler' echocardiography in paediatric dialysis patients. Nephrology (Carlton) (2009) 0.78
Evaluation of classification criteria for juvenile-onset spondyloarthropathies. Rheumatol Int (2004) 0.78